Role
Director
Signature
/s/ Nancy C. Andrews
Stock symbol
CRL
Transactions as of
May 21, 2025
Transactions value $
$407,910
Form type
4
Date filed
5/23/2025, 04:08 PM
Previous filing
Jan 30, 2025
Next filing
Sep 24, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Andrews Nancy C Director C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON /s/ Nancy C. Andrews 2025-05-23 0001804999

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Award $128K +946 +31.35% $134.98 3.96K May 21, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Award $280K +2.08K $134.98 2.08K May 21, 2025 Common Stock 2.08K $134.98 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The unvested restricted stock units vest upon the earlier of 5/21/2026 or the business day prior to the Company's next annual meeting of shareholders.
F2 The stock options become exercisable upon the earlier of 5/21/2026 or the business day prior to the Company's next annual meeting of shareholders.